The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance

Qing-Wu Yan, Qin Yang, Nimesh Mody, Timothy E. Graham, Chung-Hsin Hsu, Zhao Xu, Nicholas E. Houstis, Barbara B. Kahn, Evan D. Rosen

Research output: Contribution to journalArticle

251 Citations (Scopus)

Abstract

OBJECTIVE: We identified lipocalin 2 (Lcn2) as a gene induced by dexamethasone and tumor necrosis factor-alpha in cultured adipocytes. The purpose of this study was to determine how expression of Lcn2 is regulated in fat cells and to ascertain whether Lcn2 could be involved in metabolic dysregulation associated with obesity. RESEARCH DESIGN AND METHODS: We examined Lcn2 expression in murine tissues and in 3T3-L1 adipocytes in the presence and absence of various stimuli. We used quantitative Western blotting to observe Lcn2 serum levels in lean and obese mouse models. To assess effects on insulin action, we used retroviral delivery of short hairpin RNA to reduce Lcn2 levels in 3T3-L1 adipocytes. RESULTS: Lcn2 is highly expressed by fat cells in vivo and in vitro. Expression of Lcn2 is elevated by agents that promote insulin resistance and is reduced by thiazolidinediones. The expression of Lcn2 is induced during 3T3-L1 adipogenesis in a CCAAT/enhancer-binding protein-dependent manner. Lcn2 serum levels are elevated in multiple rodent models of obesity, and forced reduction of Lcn2 in 3T3-L1 adipocytes improves insulin action. Exogenous Lcn2 promotes insulin resistance in cultured hepatocytes. CONCLUSIONS: Lcn2 is an adipokine with potential importance in insulin resistance associated with obesity.
Original languageEnglish
Pages (from-to)2533-2540
Number of pages8
JournalDiabetes
Volume56
Issue number10
Early online date16 Jul 2007
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Adipokines
Insulin Resistance
Obesity
Adipocytes
Lipocalin-2
Insulin
CCAAT-Enhancer-Binding Proteins
Thiazolidinediones
Obese Mice
Adipogenesis
Serum
Dexamethasone
Small Interfering RNA
Hepatocytes
Rodentia
Research Design

Keywords

  • 3T3 Cells
  • acute-phase proteins
  • adipocytes
  • adipose tissue
  • animals
  • cell differentiation
  • gene expression regulation
  • insulin resistance
  • lipids
  • lipocalins
  • macrophages
  • male
  • mice
  • mice, inbred C57BL
  • mice, inbred strains
  • obesity
  • oncogene proteins
  • polymerase chain reaction
  • recombinant proteins
  • stromal cells
  • transfection

Cite this

Yan, Q-W., Yang, Q., Mody, N., Graham, T. E., Hsu, C-H., Xu, Z., ... Rosen, E. D. (2007). The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance. Diabetes, 56(10), 2533-2540. https://doi.org/10.2337/db07-0007

The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance. / Yan, Qing-Wu; Yang, Qin; Mody, Nimesh; Graham, Timothy E.; Hsu, Chung-Hsin; Xu, Zhao; Houstis, Nicholas E.; Kahn, Barbara B.; Rosen, Evan D.

In: Diabetes, Vol. 56, No. 10, 10.2007, p. 2533-2540.

Research output: Contribution to journalArticle

Yan, Q-W, Yang, Q, Mody, N, Graham, TE, Hsu, C-H, Xu, Z, Houstis, NE, Kahn, BB & Rosen, ED 2007, 'The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance', Diabetes, vol. 56, no. 10, pp. 2533-2540. https://doi.org/10.2337/db07-0007
Yan, Qing-Wu ; Yang, Qin ; Mody, Nimesh ; Graham, Timothy E. ; Hsu, Chung-Hsin ; Xu, Zhao ; Houstis, Nicholas E. ; Kahn, Barbara B. ; Rosen, Evan D. / The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance. In: Diabetes. 2007 ; Vol. 56, No. 10. pp. 2533-2540.
@article{5b26984a2feb486bbdb411942901462f,
title = "The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance",
abstract = "OBJECTIVE: We identified lipocalin 2 (Lcn2) as a gene induced by dexamethasone and tumor necrosis factor-alpha in cultured adipocytes. The purpose of this study was to determine how expression of Lcn2 is regulated in fat cells and to ascertain whether Lcn2 could be involved in metabolic dysregulation associated with obesity. RESEARCH DESIGN AND METHODS: We examined Lcn2 expression in murine tissues and in 3T3-L1 adipocytes in the presence and absence of various stimuli. We used quantitative Western blotting to observe Lcn2 serum levels in lean and obese mouse models. To assess effects on insulin action, we used retroviral delivery of short hairpin RNA to reduce Lcn2 levels in 3T3-L1 adipocytes. RESULTS: Lcn2 is highly expressed by fat cells in vivo and in vitro. Expression of Lcn2 is elevated by agents that promote insulin resistance and is reduced by thiazolidinediones. The expression of Lcn2 is induced during 3T3-L1 adipogenesis in a CCAAT/enhancer-binding protein-dependent manner. Lcn2 serum levels are elevated in multiple rodent models of obesity, and forced reduction of Lcn2 in 3T3-L1 adipocytes improves insulin action. Exogenous Lcn2 promotes insulin resistance in cultured hepatocytes. CONCLUSIONS: Lcn2 is an adipokine with potential importance in insulin resistance associated with obesity.",
keywords = "3T3 Cells, acute-phase proteins, adipocytes, adipose tissue, animals, cell differentiation, gene expression regulation, insulin resistance, lipids, lipocalins, macrophages, male, mice, mice, inbred C57BL, mice, inbred strains, obesity, oncogene proteins, polymerase chain reaction, recombinant proteins, stromal cells, transfection",
author = "Qing-Wu Yan and Qin Yang and Nimesh Mody and Graham, {Timothy E.} and Chung-Hsin Hsu and Zhao Xu and Houstis, {Nicholas E.} and Kahn, {Barbara B.} and Rosen, {Evan D.}",
year = "2007",
month = "10",
doi = "10.2337/db07-0007",
language = "English",
volume = "56",
pages = "2533--2540",
journal = "Diabetes",
issn = "0012-1797",
publisher = "AMER DIABETES ASSOC",
number = "10",

}

TY - JOUR

T1 - The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance

AU - Yan, Qing-Wu

AU - Yang, Qin

AU - Mody, Nimesh

AU - Graham, Timothy E.

AU - Hsu, Chung-Hsin

AU - Xu, Zhao

AU - Houstis, Nicholas E.

AU - Kahn, Barbara B.

AU - Rosen, Evan D.

PY - 2007/10

Y1 - 2007/10

N2 - OBJECTIVE: We identified lipocalin 2 (Lcn2) as a gene induced by dexamethasone and tumor necrosis factor-alpha in cultured adipocytes. The purpose of this study was to determine how expression of Lcn2 is regulated in fat cells and to ascertain whether Lcn2 could be involved in metabolic dysregulation associated with obesity. RESEARCH DESIGN AND METHODS: We examined Lcn2 expression in murine tissues and in 3T3-L1 adipocytes in the presence and absence of various stimuli. We used quantitative Western blotting to observe Lcn2 serum levels in lean and obese mouse models. To assess effects on insulin action, we used retroviral delivery of short hairpin RNA to reduce Lcn2 levels in 3T3-L1 adipocytes. RESULTS: Lcn2 is highly expressed by fat cells in vivo and in vitro. Expression of Lcn2 is elevated by agents that promote insulin resistance and is reduced by thiazolidinediones. The expression of Lcn2 is induced during 3T3-L1 adipogenesis in a CCAAT/enhancer-binding protein-dependent manner. Lcn2 serum levels are elevated in multiple rodent models of obesity, and forced reduction of Lcn2 in 3T3-L1 adipocytes improves insulin action. Exogenous Lcn2 promotes insulin resistance in cultured hepatocytes. CONCLUSIONS: Lcn2 is an adipokine with potential importance in insulin resistance associated with obesity.

AB - OBJECTIVE: We identified lipocalin 2 (Lcn2) as a gene induced by dexamethasone and tumor necrosis factor-alpha in cultured adipocytes. The purpose of this study was to determine how expression of Lcn2 is regulated in fat cells and to ascertain whether Lcn2 could be involved in metabolic dysregulation associated with obesity. RESEARCH DESIGN AND METHODS: We examined Lcn2 expression in murine tissues and in 3T3-L1 adipocytes in the presence and absence of various stimuli. We used quantitative Western blotting to observe Lcn2 serum levels in lean and obese mouse models. To assess effects on insulin action, we used retroviral delivery of short hairpin RNA to reduce Lcn2 levels in 3T3-L1 adipocytes. RESULTS: Lcn2 is highly expressed by fat cells in vivo and in vitro. Expression of Lcn2 is elevated by agents that promote insulin resistance and is reduced by thiazolidinediones. The expression of Lcn2 is induced during 3T3-L1 adipogenesis in a CCAAT/enhancer-binding protein-dependent manner. Lcn2 serum levels are elevated in multiple rodent models of obesity, and forced reduction of Lcn2 in 3T3-L1 adipocytes improves insulin action. Exogenous Lcn2 promotes insulin resistance in cultured hepatocytes. CONCLUSIONS: Lcn2 is an adipokine with potential importance in insulin resistance associated with obesity.

KW - 3T3 Cells

KW - acute-phase proteins

KW - adipocytes

KW - adipose tissue

KW - animals

KW - cell differentiation

KW - gene expression regulation

KW - insulin resistance

KW - lipids

KW - lipocalins

KW - macrophages

KW - male

KW - mice

KW - mice, inbred C57BL

KW - mice, inbred strains

KW - obesity

KW - oncogene proteins

KW - polymerase chain reaction

KW - recombinant proteins

KW - stromal cells

KW - transfection

U2 - 10.2337/db07-0007

DO - 10.2337/db07-0007

M3 - Article

VL - 56

SP - 2533

EP - 2540

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 10

ER -